Pharmacokinetics of CAR T cells in multiple myeloma - the good, the bad, and the ugly - PubMed
18 hours ago
- #CAR T cells
- #pharmacokinetics
- #multiple myeloma
- CAR T cell pharmacokinetics in multiple myeloma has positive, negative, and complex aspects.
- Competing interests and funding disclosures involve multiple pharmaceutical companies and research grants.
- Reference to a 2018 study shows CAR T cells targeting B-cell maturation antigen induce remissions in relapsed multiple myeloma.